Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Brain Neoplasms 21Central Nervous System Neoplasms 6Glioma 5Neoplasm Metastasis 4Glioblastoma 4Radiation Injuries 3Small Cell Lung Carcinoma 2Oligodendroglioma 2Neurotoxicity Syndromes 2Neoplasms 2Meningioma 2Medulloblastoma 2Lung Neoplasms 2Gliosarcoma 2Ependymoma 2Craniopharyngioma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Astrocytoma 2Seizures 1Pinealoma 1Ototoxicity 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Meningeal Carcinomatosis 1Melanoma 1Glioma, Subependymal 1Fatigue 1Cognitive Dysfunction 1Cognition Disorders 1

Interventions

merphos 1Vincristine 1Methotrexate 1Mental Status and Dementia Tests 1Etoposide 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Basal Cell Nevus Syndrome × Mental Status and Dementia Tests × CNS × Clear all
NCT02017964 2023-01-09

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Children's Oncology Group

Phase 2 Completed
26 enrolled 14 charts
CNSDermatologic

Basal Cell Nevus Syndrome, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡